Skip to main content

Find Clinical Trials

Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,027 public trials 1,169 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

NCT05969496

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

Hilands Ranch Hospital Highlands Ranch, Colorado, United States

Lone Tree Medical Center Lone Tree, Colorado, United States

View Trial Details

Recruiting

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

NCT06726161

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Research Facility Birmingham, Alabama, United States

Research Facility Phoenix, Arizona, United States

Research Facility Tucson, Arizona, United States

Research Facility Orange, California, United States

View all 13 locations

View Trial Details

Recruiting

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

NCT06753136

Conditions: Abdominal and/or Peritoneal Localizations, Adenocarcinoma, Carcinoma, +36 more
Locations: Istituto Oncologico Veneto Padova, Italy

View Trial Details

Recruiting

Electronic Symptom Monitoring of Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial

NCT06938945

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: China Center for Health Development Studies, Peking University Haidian, Beijing Municipality, China

View Trial Details

Recruiting

Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)

NCT07293468

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tuen Mun Hospital Hong Kong

View Trial Details

Recruiting

Streamlining Radioembolization for Small HCC

NCT06979219

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: National Cancer Center Goyang, South Korea

Samsung Medical Center Seoul, South Korea

Seoul National University Hospital Seoul, South Korea

Severance hospital Seoul, South Korea

View Trial Details

Recruiting

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

NCT05048212

Conditions: Adenocarcinoma, Brain Diseases, Brain Metastases, +21 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

NCT06141369

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +27 more
Locations: Ruijin hospital, Shanghai Jiao-Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Same-day Radioembolization for Large HCC

NCT06944483

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: National Cancer Center Goyang, South Korea

Samsung Medical Center Seoul, South Korea

Seoul National University Hospital Seoul, South Korea

Severance hospital Seoul, South Korea

View Trial Details

Recruiting

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

NCT07214532

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic Arizona Phoenix, Arizona, United States

Honor Health Research Institute Scottsdale, Arizona, United States

University of Arizona Cancer Center Tucson, Arizona, United States

View all 39 locations

View Trial Details